FDA Inspection 1235786 — Yves Dauvilliers, M.D., Ph.D.
The FDA completed an inspection of Yves Dauvilliers, M.D., Ph.D. on March 22, 2024 in Montpellier. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 22, 2024
- Fiscal Year
- 2024
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Montpellier (France)
Additional Details
Clinical Investigator (CI)